| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 172 |
| 1 | ASPIRIN 325 MG | 162 |
| 2 | ASPIRIN 81 MG | 162 |
| 3 | RIVAROXABAN | 131 |
| 4 | CLOPIDOGREL | 122 |
| 5 | FUROSEMIDE | 85 |
| 6 | CLOPIDOGREL BISULFATE | 81 |
| 7 | IBUPROFEN | 78 |
| 8 | WARFARIN | 68 |
| 9 | PANTOPRAZOLE | 65 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANAGRELIDE HYDROCHLORIDE | 5 | 0.0043 |
| 1 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE | 9 | 0.0028 |
| 2 | DACTINOMYCIN | 4 | 0.0018 |
| 3 | DASATINIB | 12 | 0.0013 |
| 4 | HYDROCORTISONE SODIUM SUCCINATE | 5 | 0.0013 |
| 5 | DIMENHYDRINATE | 13 | 0.0012 |
| 6 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 12 | 0.0010 |
| 7 | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 6 | 0.0010 |
| 8 | MAGNESIUM CITRATE ORAL SOLUTION | 6 | 0.0010 |
| 9 | MAGNESIUM CITRATE | 6 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 290 |
| 1 | Factor Xa Inhibitor [EPC] | 187 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 179 |
| 3 | Corticosteroid [EPC] | 102 |
| 4 | Loop Diuretic [EPC] | 95 |
| 5 | Proton Pump Inhibitor [EPC] | 82 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 72 |
| 7 | P2Y12 Platelet Inhibitor [EPC] | 71 |
| 8 | Benzodiazepine [EPC] | 59 |
| 9 | Platinum-based Drug [EPC] | 59 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 11 | 0.0160 |
| 1 | Actinomycin [EPC] | 4 | 0.0018 |
| 2 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 2 | 0.0016 |
| 3 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 2 | 0.0013 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 5 | Provitamin D2 Compound [EPC] | 28 | 0.0009 |
| 6 | Factor Xa Inhibitor [EPC] | 187 | 0.0007 |
| 7 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 4 | 0.0006 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 71 | 0.0006 |